Skip to main navigation Skip to search Skip to main content

Novel GLP-1R/GIPR co-agonist “twincretin” is neuroprotective in cell and rodent models of mild traumatic brain injury

  • Ian A. Tamargo
  • , Miaad Bader
  • , Yazhou Li
  • , Seong Jin Yu
  • , Yun Wang
  • , Konrad Talbot
  • , Richard D. DiMarchi
  • , Chaim G. Pick
  • , Nigel H. Greig

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)176-186
Number of pages11
JournalExperimental Neurology
Volume288
DOIs
StatePublished - Feb 1 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Neurology
  • Developmental Neuroscience

Keywords

  • Glucagon-like peptide-1
  • Glucose-dependent insulinotropic peptide
  • Incretin
  • Incretin mimetic
  • Neurodegeneration
  • Traumatic brain injury
  • CREB-Binding Protein/metabolism
  • Recognition, Psychology/drug effects
  • Embryo, Mammalian
  • Humans
  • Male
  • Receptors, Gastrointestinal Hormone/agonists
  • Body Temperature/drug effects
  • Neuroblastoma/pathology
  • Brain Injuries, Traumatic/complications
  • Incretins/therapeutic use
  • Disease Models, Animal
  • Reactive Oxygen Species/metabolism
  • Glucagon-Like Peptide-1 Receptor/metabolism
  • Neuroprotective Agents/therapeutic use
  • Glucagon-Like Peptide 1/metabolism
  • Cells, Cultured
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction/drug effects
  • Mice, Inbred ICR
  • Animals
  • Memory Disorders/etiology
  • Cell Line, Tumor
  • Mice
  • Maze Learning/drug effects
  • Glucagon-Like Peptide-1 Receptor Agonists

Cite this